Emerging Molecular Markers of Cancer in Washington (August 21-23, 2012)

The interest in molecular markers for cancer is growing stronger and is a critical component of personalized therapy. Cancer biomarkers serve many uses, from early detection to differential diagnosis and therapeutic monitoring. They require high sensitivity and specificity to be effective, and serum biomarkers offer a chance of gaining information in a non-invasive manner. Additional biomarkers need to be identified to enable personalized therapy and different classes of markers, including nucleic acid and protein, need to be combined. These will require advanced informatics capabilities and the end result will be clinical use of biomarkers.

http://www.nextgenerationdx.com/cdx

Edited by : GIGA, Aline Lausberg